爱柯迪(600933.SH)拟回购注销12.56万股限制性股票
格隆汇12月31日丨爱柯迪(600933.SH)公布,鉴于激励对象有2人第一个解除限售期的考核结果为“B”,解除限售额度为80%,公司将对这2人已获授但尚未解除限售的限制性股票合计2.56万股进行回购注销的处理。根据《爱柯迪股份有限公司第三期限制性股票激励计划(草案)》的相关规定,鉴于激励对象中有1人因个人原因已离职并失去本次股权激励资格,公司将对其持有的尚未解除限售的限制性股票10万股进行回购注销的处理。注销日期2020年1月6日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.